CASC15, an oncogenic factor in tumorigenesis of various cancers including BrC [51], is known to promote EMT by increasing N-cadherin and vimentin protein levels while decreasing that of E-cadherin via TWIST1 [52]. This evidence concerns the gene CDH2 and cancer.